PRFXPainReform Ltd.

PRFX Stock Price, Valuation & Chart | PainReform Ltd.

$0.970+0.02 (+2.45%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic PRFX intrinsic value PRFX calculated fair value vs price

Overview Financials Dividends Ratios

PRFX Historical price chart

PRFX Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization78.48K

PE Ratio-0.01

EPS-116.8

Trading Volume25.79K

Today's High/Low0.98/0.94

Dividend Yield0.00

52 Week High/Low9.0/0.91

Shares Outstanding80.53K

PRFX Financial Statement

PRFX Analyst ratings

PRFX Analysis & performance metrics

PRFX Company profile

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief…

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently…

PRFX Management team

Name

Position

Sigal Aviel eMBA, Ph.D.COO

Chief Operating Officer

Eli Hazum Ph.D.CTO

Chief Technology Officer & Director

Ehud Geller Ph.D.CEO

Interim Chief Executive Officer & Executive Chairman

Stephen A. Cooper D.M.D Ph.D.

Executive Vice President of Development

Rita Keynan

Vice President of Pharmaceutical Operations

Eyal BroderCFO

Interim Chief Financial Officer

Name

Position

Sigal Aviel eMBA, Ph.D.COO

Chief Operating Officer

Eli Hazum Ph.D.CTO

Chief Technology Officer & Director

Ehud Geller Ph.D.CEO

Interim Chief Executive Officer & Executive Chairman

Stephen A. Cooper D.M.D Ph.D.

Executive Vice President of Development

Rita Keynan

Vice President of Pharmaceutical Operations

Eyal BroderCFO

Interim Chief Financial Officer

Management Team

Sigal Aviel eMBA, Ph.D.COO

Chief Operating Officer

Eli Hazum Ph.D.CTO

Chief Technology Officer & Director

Ehud Geller Ph.D.CEO

Interim Chief Executive Officer & Executive Chairman

Stephen A. Cooper D.M.D Ph.D.

Executive Vice President of Development

Rita Keynan

Vice President of Pharmaceutical Operations

Eyal BroderCFO

Interim Chief Financial Officer

Management

Sigal Aviel eMBA, Ph.D.COO

Chief Operating Officer

Eli Hazum Ph.D.CTO

Chief Technology Officer & Director

Ehud Geller Ph.D.CEO

Interim Chief Executive Officer & Executive Chairman

Stephen A. Cooper D.M.D Ph.D.

Executive Vice President of Development

Rita Keynan

Vice President of Pharmaceutical Operations

Eyal BroderCFO

Interim Chief Financial Officer

Total 6 executives

PRFX Frequently asked questions

What is PainReform Ltd. (PRFX) Stock Price?

Current stock price of PainReform Ltd. (PRFX) stock is $0.970. The stock price is +2.45% higher in the session. The intraday range can be seen from this page. Volume of PainReform Ltd. (PRFX) stock is 25.79K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the PainReform Ltd. (PRFX) stock price going up or down today?

The stock price of PainReform Ltd. (PRFX) can change with earnings, company news, and overall market sentiment. PainReform Ltd. operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the PainReform Ltd. stock expensive at its current price?

Whether PainReform Ltd. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PRFX on this page is -0.01. EPS on this page is -116.81. Compare those figures with peers and growth expectations before deciding if the current PainReform Ltd. price is justified.

How has the stock price of PainReform Ltd. (PRFX) performed historically?

Historical performance for PainReform Ltd. (PRFX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PRFX reacted to past earnings and market events.

Should I buy PainReform Ltd. (PRFX) stock, at this price?

Buying PainReform Ltd. (PRFX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.